Incidence and treatment of metachronous gastric cancer after proximal gastrectomy
Background and purpose
Proximal gastrectomy (PG) is a widely accepted function-preserving surgical procedure; however, the incidence and treatment of metachronous gastric cancer (MGC) after PG have been the subject of a number of reports.
We collected data from 1576 consecutive patients who underwent gastrectomy for gastric cancer between January, 2003 and December, 2010, and analyzed the outcomes of 671 patients treated with PG or distal gastrectomy (DG) for cT1N0 disease. We also discuss the treatments for MGC.
MGC was diagnosed within a median follow-up of 52.8 months after PG and DG in six (6.6%) and nine (1.8%) patients, respectively. The cumulative prevalence of MGC after PG was significantly higher than that after DG; P = 0.005. Univariate and multivariate analysis revealed male sex and PG as significant risk factors for MGC (P = 0.014 and P = 0.026, respectively). Five of the six patients who underwent PG were treated by endoscopic submucosal dissection.
The incidence of MGC after PG was significantly higher than that after DG. However, most of the MGCs that developed after PG could be treated by endoscopic submucosal dissection.
KeywordsGastric remnant cancer Metachronous gastric cancer Proximal gastrectomy Endoscopic submucosal dissection Endoscopic surveillance
This work was supported in part by a Health Labour Sciences Research Grant (H26-053).
Compliance with ethical standards
Conflict of interest
We have no conflicts of interest to declare.
- 10.Guidelines for Diagnosis and Treatment of Carcinoma of the Stomach April 2004 edition. Japanese Gastric Cancer Society. 2004. http://www.jgca.jp/pdf/Guidelines2004_eng.pdf. Accessed 10 Apr 2017.
- 29.Helge LW, Liv S, Patricia M. Gastrin and gastric cancer. Front Endocrinol. 2017;8:1–7.Google Scholar
- 33.Mori G, Nakajima T, Asada K, Shimazu T, Yamamichi N, Maekita T, et al. Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication: results of a large-scale, multicenter cohort study in Japan. Gastric Cancer. 2016;19:911–8.CrossRefPubMedGoogle Scholar